The stress protein gp96 is not an activator of resting rat bone marrow-derived dendritic cells, but is a costimulator and activator of CD33 + T cells

Cell Stress and Chaperones

Volumn 11, Issue 4, 2006, Pages 364-378

  Mirza, Shabana ^a   Muthana, Munitta ^a   Fairburn, Barbara ^a   Slack, Laura K ^a   Hopkinson, Kay ^a   Pockley, A Graham ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GP96 PROTEIN; HEAT SHOCK PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; UNCLASSIFIED DRUG; CD28 ANTIGEN; CD3 ANTIGEN; ENDOPLASMIN; FLUORESCEIN ISOTHIOCYANATE; MEMBRANE PROTEIN;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL SURFACE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENDRITIC CELL; DOSE RESPONSE; HELPER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ANIMAL; DRUG EFFECT; ISOLATION AND PURIFICATION; LEWIS RAT; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; BONE MARROW CELLS; DENDRITIC CELLS; FLUORESCEIN-5-ISOTHIOCYANATE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED LEW; RATS, WISTAR; T-LYMPHOCYTES;

EID: 33947586858     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1379/CSC-208.1     Document Type: Article

References (66)

1. Arnold-Schild D, Hanau D, Spehner D, Schmid C, Rammensee H-G, de la Salle H, Schild H. 1999. Receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J Immunol 162: 3757-3760.
2. Arnold-Schild D, Kleist C, Welschof M, Opelz G, Rammensee HG, Schild H, Terness P. 2000. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development. Cancer Res 60: 4175-4178.
3. Baker-LePain JC, Reed RC, Nicchitta CV. 2003. ISO: a critical evaluation of the role of peptides in heat shock/chaperone protein-mediated tumor rejection. Curr Opin Immunol 15: 89-94.
4. Baker-LePain JC, Sarzotti M, Fields TA, Li CY, Nicchitta CV. 2002. GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression. J Exp Med 196: 1447-1459.
5. Banerjee PP, Vinay DS, Mathew A, et al. 2002. Evidence that glycoprotein 96 (B2), a stress protein, functions as a Th2-specific costimulatory molecule. J Immunol 169: 3507-3518.
6. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activates the NF-κB pathway. Int Immunol 12: 1539-1546.
7. Berwin B, Hart JP, Pizzo SV, Nicchitta CV. 2002. CD91-independent cross-presentation of grp94 (gp96)-associated peptides. J Immunol 168: 4282-4286.
8. Bethke K, Staib F, Distler M, Schmitt U, Jonuleit H, Enk AH, Galle PR, Heike M. 2002. Different efficiency of heat shock proteins to activate human monocytes and dendritic cells: superiority of HSP60. J Immunol 169: 6141-6148.
9. Binder RJ, Han DK, Srivastava PK. 2000. CD91: a receptor for heat shock protein gp96. Nat Immunol 1: 151-155.
10. Binder RJ, Srivastava PK. 2004. Essential role of CD91 in re-presentation of gp96-chaperoned peptides. Proc Natl Acad Sci U S A 101: 6128-6133.
11. Binder RJ, Vatner R, Srivastava P. 2004. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64: 442-451.
12. Brenan M, Puklavec M. 1992. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J Exp Med 175: 1457-1465.
13. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411.
14. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct pathways. J Exp Med 191: 1957-1964.
15. Chandawarkar RY, Wagh MS, Kovalchin JT, Srivastava P. 2004. Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis. Int Immunol 16: 615-624.
16. Chandawarkar RY, Wagh MS, Srivastava PK. 1999. The dual nature of specific immunological activity of tumor-derived gp96 preparations. J Exp Med 189: 1437-1442.
17. Cottrez F, Hurst SD, Coffman RL, Groux H. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165: 4848-4853.
18. Delamarre L, Holcombe H, Mellman I. 2003. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 198: 111-122.
19. + T cell effector function. J Immunol 172: 6087-6092.
20. Fairburn B, Muthana M, Hopkinson K, et al. 2006. Analysis of purified gp96 preparations from rat and mouse livers using 2-D gel electrophoresis and tandem mass spectrometry. Biochimie, in press.
21. Frank SJ. 2002. Receptor dimerization in GH and erythropoietin action - it takes two to tango, but how? Endocrinology 143: 2-10.
22. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA. 1992. Rational design of potent antagonists to the human growth hormone receptor. Science 256: 1677-1680.
23. Gallucci S, Lolkema M, Matzinger P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nature Med 11: 1249-1255.
24. + T cells. Curr Opin Immunol 15: 690-696.
25. Gething MJ, Sambrook J. 1992. Protein folding in the cell. Nature 355: 33-45.
26. Groux H. 2003. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 75(9 Suppl): 8S-12S.
27. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
28. - and Type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG. J Immunol 172: 7485-7494.
29. + Th1 cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to IFN-γ or IL-2 determines their function. Int Immunol 7: 1287-1294.
30. Koch G, Smith M, Macer D, Webster P, Mortara R. 1986. Endoplasmic reticulum contains a common, abundant calcium-binding glycoprotein, endoplasmin. J Cell Sci 86: 217-222.
31. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. 2004. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 101: 3029-3034.
32. Lagaraine C, Hoarau C, Chabot V, Velge-Roussel F, Lebranchu Y. 2005. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Int Immunol 17: 351-363.
33. Lee AS. 1981. The accumulation of three specific proteins related to glucose-regulated proteins in a temperature-sensitive hamster mutant cell line K12. J Cell Physiol 106: 119-125.
34. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 172: 6539-6544.
35. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM. 2004. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 173: 1179-1183.
36. Lewis MJ, Mazzarella RA, Green M. 1985. Structure and assembly of the endoplasmic reticulum. The synthesis of three major endoplasmic reticulum proteins during lipopolysaccharide-induced differentiation of murine lymphocytes. J Biol Chem 260: 3050-3057.
37. Liew FY, Komai-Koma M, Xu D. 2004. A toll for T cell costimulation. Ann Rheum Dis 63(Suppl 2): ii76-ii78.
38. Lipscomb MF, Masten BJ. 2002. Dendritic cells: immune regulators in health and disease. Physiol Rev 82: 97-130.
39. Lyons AB, Parish CR. 1994. Determination of lymphocyte division by flow cytometry. J Immunol Methods 171: 131-137.
40. Monks SA, Gaibor FP, Hassan-Zahraee M, Sawlivich W, Liu C, Rottman JB, Zabrecky JR. 2005. The role of oligomeric structure in the biological activities of heat-shock protein, gp96. Immunology 114: 148.
41. Muthana M, Fairburn B, Mirza S, Slack LK, Hopkinson K, Pockley AG. 2006. Identification of a rat bone marrow-derived dendritic cell population which secretes both IL-10 and IL-12: evidence against a reciprocal relationship between IL-10 and IL-12 secretion. Immunobiology 211: 391-402.
42. Muthana M, Fairburn B, Mirza S, Slack LK, Pockley AG. 2004. Systematic evaluation of the conditions required for the generation of immature rat bone marrow-derived dendritic cells and their phenotypic and functional characterization. J Immunol Methods 294: 165-179.
43. Nicchitta CV. 2003. Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat Rev Immunol 3: 427-432.
44. Norbury CC. 2006. Drinking a lot is good for dendritic cells. Immunology 117: 443-451.
45. Pierre P, Turley SJ, Gatti E, et al. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388: 787-792.
46. Reed RC, Berwin B, Baker JP, Nicchitta CV. 2003. GRP94/gp96 elicits ERK activation in murine macrophages. A role for endotoxin contamination in NF-κB activation and nitric oxide production. J Biol Chem 278: 31853-31860.
47. SenGupta D, Norris PJ, Suscovich TJ, et al. 2004. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J Immunol 173: 1987-1993.
48. + suppressor T cells: more questions than answers. Nat Rev Immunol 2: 389-400.
49. Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee H-G, Toes REM, Schild H. 2000a. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30: 2211-2215.
50. Singh-Jasuja H, Toes REM, Spee P, et al. 2000b. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex molecules requires receptor-mediated endocytosis. J Exp Med 191: 1965-1974.
51. Srivastava P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Ann Rev Immunol 20: 395-425.
52. Srivastava PK. 1997. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods 12: 165-171.
53. Srivastava PK, DeLeo AB, Old LJ. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A 83: 3407-3411.
54. Srivastava PK, Udono H. 1994. Heat shock protein-peptide complexes in cancer immunotherapy. Cur Opin Immunol 6: 728-732.
55. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9: 271-296.
56. Talmor M, Mirza A, Turley S, Mellman I, Hoffman LA, Steinman RM. 1998. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 28: 811-817.
57. Trinité B, Voisine C, Yagita H, Josien R. 2000. A subset of cytolytic dendritic cells in rat. J Immunol 165: 4202-4208.
58. Udono H, Srivastava PK. 1994. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J Immunol 152: 5398-5403.
59. Vabulas RM, Braedel S, Hilf N, et al. 2002a. The endoplasmic reticulum -resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 277: 20847-20853.
60. Vabulas RM, Wagner H, Schild H. 2002b. Heat shock proteins as ligands of Toll-like receptors. Cur Top Microbiol Immunol 270: 169-184.
61. Waldmann H, Graca L, Cobbold S, Adams E, Tone M, Tone Y. 2004. Regulatory T cells and organ transplantation. Semin Immunol 16: 119-126.
62. Warger T, Hilf N, Rechtsteiner G, et al. 2006. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 281: 22545-22553.
63. Wood KJ, Sakaguchi S. 2003. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210.
64. Young D, Romain E, Moreno C, O'Brien R, Born W. 1993. Molecular chaperones and the immune system response. Phil Trans R Soc Lond 339: 363-367.
65. + regulatory T cell function via innate TLR2 signaling J Clin Invest 116: 2022-2032.
66. Zheng H, Dai J, Stoilova D, Li Z. 2001. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J Immunol 167: 6734-6735.